A Study of ASP3082 in Adults With Advanced Solid Tumors
for Solid Tumor
24 locations incl. Duarte
Sponsor: Astellas Pharma Inc
Sex: All·Age: 18+
Code: NCT05382559·Phase 1·Recruiting·Listed May 2022
Florida Cancer Specialists - Sarasota
Clinical research site in Sarasota, Florida · 600 N CATTLEMEN RD, SUITE #200, SARASOTA, FL 34232-6422 · (941) 377-9993 · Website
Part of Florida Cancer Specialists
As of July 2026, 23 paid clinical trials are recruiting at Florida Cancer Specialists - Sarasota in Sarasota, Florida. Active studies at this site cover conditions such as Head and Neck Squamous Cell Carcinoma, Triple Negative Breast Cancer and Advanced Cancer. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Recruiting clinical trials at Florida Cancer Specialists - Sarasota (23)
A First-in-Human Study of MEN2312 in Adults With Advanced Breast Cancer
for Advanced Breast Cancer
37 locations incl. Springdale
Sponsor: Stemline Therapeutics, Inc.
Sex: All·Age: 18+
Code: NCT06638307·Phase 1·Recruiting·Listed Oct 2024
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
for Urothelial Carcinoma
144 locations incl. Gilbert
Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Sex: All·Age: 18+
Code: NCT04879329·Phase 2·Recruiting·Listed May 2021
ONC-392 Versus Docetaxel in Metastatic NSCLC That Progressed on PD-1/PD-L1 Inhibitors
for Non Small Cell Lung Cancer
46 locations incl. Dothan
Sponsor: OncoC4, Inc.
Sex: All·Age: 18+
Code: NCT05671510·Phase 3·Recruiting·Listed Jan 2023
A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
for Lymphoma, Non-Hodgkin's
21 locations incl. Scottsdale
Sponsor: Eli Lilly and Company
Sex: All·Age: 18+
Code: NCT07226843·Phase 1·Recruiting·Listed Nov 2025
A Study of LY4175408 in Participants With Advanced Cancer
for Carcinoma, Non-Small-Cell Lung
15 locations incl. Stanford
Sponsor: Eli Lilly and Company
Sex: All·Age: 18+
Code: NCT07046923·Phase 1·Recruiting·Listed Jul 2025
A Study to Evaluate the Safety, Pharmacokinetics, and Activity of Enzelkitug as a Single Agent and in Combination With Checkpoint Inhibitor in Participants With Locally Advanced or Metastatic Solid Tumors
for Locally Advanced or Metastatic Solid Tumors
9 locations incl. San Francisco
Sponsor: Genentech, Inc.
Sex: All·Age: 18+
Code: NCT05581004·Phase 1·Recruiting·Listed Oct 2022
A Study of JZP815 Oral Capsules in Adult Participants With Advanced or Metastatic Solid Tumors Harboring Mitogen Activated Protein Kinase (MAPK) Pathway Alterations to Investigate the Safety, Dosing, and Antitumor Activity of JZP815
for Advanced Cancer
15 locations incl. Los Angeles
Sponsor: Jazz Pharmaceuticals
Sex: All·Age: 18+
Code: NCT05557045·Phase 1·Recruiting·Listed Sep 2022
Phase 1 Study of ACR-2316 in Specific Advanced Solid Tumors
for Specific Advanced Solid Tumors
15 locations incl. Phoenix
Sponsor: Acrivon Therapeutics
Sex: All·Age: 18+
Code: NCT06667141·Phase 1·Recruiting·Listed Oct 2024
A Study to Investigate the Safety and Efficacy of KQB168 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies
for Solid Tumor Malignancies
15 locations incl. Phoenix
Sponsor: Kumquat Biosciences Inc.
Sex: All·Age: 18+
Code: NCT06994806·Phase 1·Recruiting·Listed May 2025
A Study to Investigate the Safety and Efficacy of KQB198 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies
for Solid Tumor, Adult
9 locations incl. Denver
Sponsor: Kumquat Biosciences Inc.
Sex: All·Age: 18+
Code: NCT06507306·Phase 1·Recruiting·Listed Jul 2024
A First-in-Human Study of MEN2501 in Participants With Platinum-Resistant Ovarian Cancer
for Platinum-resistant Ovarian Cancer
7 locations incl. Springdale
Sponsor: Stemline Therapeutics, Inc.
Sex: Female·Age: 18+
Code: NCT07226427·Phase 1·Recruiting·Listed Nov 2025
A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors
for Metastatic Solid Tumors
7 locations incl. Sarasota
Sponsor: Erasca, Inc.
Sex: All·Age: 18 - 99
Code: NCT06983743·Phase 1·Recruiting·Listed May 2025
A Phase 1 of CTX-8371 in Patients With Advanced Malignancies
for Non Small Cell Lung Cancer
8 locations incl. Orlando
Sponsor: Compass Therapeutics
Sex: All·Age: 18+
Code: NCT06150664·Phase 1·Recruiting·Listed Nov 2023
A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
for Cancer
6 locations incl. Los Angeles
Sponsor: Angiex, Inc.
Sex: All·Age: 18+
Code: NCT06440005·Phase 1·Recruiting·Listed Jun 2024
A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer
for Metastatic Castration-resistant Prostate Cancer
7 locations incl. Palo Alto
Sponsor: Bristol-Myers Squibb
Sex: Male·Age: 18+
Code: NCT06067841·Phase 1·Recruiting·Listed Oct 2023
A Study to Investigate APL-5125 in Adults With Advanced Solid Tumors
for Colorectal Cancer
7 locations incl. Sarasota
Sponsor: Apollo Therapeutics Ltd
Sex: All·Age: 18+
Code: NCT06399757·Phase 1, Phase 2·Recruiting·Listed May 2024
A Study of Oral MBQ-167 in Participants With Advanced Breast Cancer
for Breast Cancer
3 locations incl. Beverly Hills
Sponsor: MBQ Pharma
Sex: All·Age: 21+
Code: NCT06075810·Phase 1·Recruiting·Listed Oct 2023
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
for Breast Cancer
1105 locations incl. Anchorage
Sponsor: NRG Oncology
Sex: Female·Age: 18 - 60
Code: NCT05879926·Phase 3·Recruiting·Listed May 2023
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
for Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
146 locations incl. Gilbert
Sponsor: NRG Oncology
Sex: All·Age: 18+
Code: NCT06532279·Phase 2·Recruiting·Listed Aug 2024
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
for Stage I Breast Cancer
707 locations incl. Mobile
Sponsor: NRG Oncology
Sex: All·Age: 50 - 70
Code: NCT04852887·Phase 3·Recruiting·Listed Apr 2021
Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER
for Endometrial Cancer
72 locations incl. Anchorage
Sponsor: Canadian Cancer Trials Group
Sex: Female·Age: 18+
Code: NCT05640999·Phase 2·Recruiting·Listed Dec 2022
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
for Ovarian Carcinoma
473 locations incl. Birmingham
Sponsor: NRG Oncology
Sex: Female·Age: 35 - 50
Code: NCT04251052·Recruiting·Listed Jan 2020
More research sites in Sarasota
- Florida Cancer Specialists (43 trials)
- Sarasota Memorial Hospital (27 trials)
- Sarasota Memorial Health Care System (18 trials)
- Intercoastal Medical Group (6 trials)
- Florida Cancer Specialists - Sarasota Downtown (5 trials)
- Sarasota Memorial Healthcare System (5 trials)
- First Physicians Group-Sarasota (4 trials)
- Sarasota Memorial Health Care Center at University Parkway (4 trials)
- The Roskamp Institute (4 trials)
- First Physicians Group - Silverstein Institute at Floyd Street (3 trials)
Explore more
Paid clinical trials in Sarasota, FL · Florida clinical trials